Erin S Beck1, Neville Gai2, Stefano Filippini, Josefina Maranzano3, Govind Nair1, Daniel S Reich1. 1. From the Translational Neuroradiology Section, National Institute of Neurological Disorders and Stroke. 2. Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD. 3. University of Quebec in Trois-Rivieres, Trois-Rivieres, Quebec, Canada.
Abstract
OBJECTIVES: Cortical demyelination is common in multiple sclerosis (MS) and can be extensive. Cortical lesions contribute to disability independently from white matter lesions and may form via a distinct mechanism. However, current magnetic resonance imaging methods at 3 T are insensitive to cortical, and especially subpial cortical, lesions. Subpial lesions are well seen on T2*-weighted imaging at 7 T, but T2*-weighted methods on 3 T scanners are limited by poor lesion-to-cortex and cerebrospinal fluid-to-lesion contrast. We aimed to develop and evaluate a cerebrospinal fluid-suppressed, T2*-weighted sequence optimized for subpial cortical lesion visualization. MATERIALS AND METHODS: We developed a new magnetic resonance imaging sequence, inversion recovery susceptibility weighted imaging with enhanced T2 weighting (IR-SWIET; 0.8 mm × 0.8 mm in plane, 0.64 mm slice thickness with whole brain coverage, acquisition time ~5 minutes). We compared cortical lesion visualization independently on IR-SWIET (median signal from 4 acquisitions), magnetization-prepared 2 rapid acquisition gradient echoes (MP2RAGE), double inversion recovery (DIR), T2*-weighted segmented echo-planar imaging, and phase-sensitive inversion recovery images for 10 adults with MS. We also identified cortical lesions with a multicontrast reading of IR-SWIET (median of 2 acquisitions), MP2RAGE, and fluid-attenuated inversion recovery (FLAIR) images for each case. Lesions identified on 3 T images were verified on "gold standard" 7 T T2* and MP2RAGE images. RESULTS: Cortical, and particularly subpial, lesions appeared much more conspicuous on IR-SWIET compared with other 3 T methods. A total of 101 true-positive subpial lesions were identified on IR-SWIET (average per-participant sensitivity vs 7 T, 29% ± 8%) versus 36 on MP2RAGE (5% ± 2%; comparison to IR-SWIET sensitivity, P = 0.07), 17 on FLAIR (2% ± 1%; P < 0.05), 28 on DIR (6% ± 2%; P < 0.05), 42 on T2*-weighted segmented echo-planar imaging (11% ± 5%; P < 0.05), and 13 on phase-sensitive inversion recovery (4% ± 2%; P < 0.05). When a combination of IR-SWIET, MP2RAGE, and FLAIR images was used, a total of 147 subpial lesions (30% ± 5%) were identified versus 83 (16% ± 3%, P < 0.01) on a combination of DIR, MP2RAGE, and FLAIR. More cases had at least 1 subpial lesion on IR-SWIET, and IR-SWIET improved cortical lesion subtyping accuracy and correlation with 7 T subpial lesion number. CONCLUSIONS: Subpial lesions are better visualized on IR-SWIET compared with other 3 T methods. A 3 T protocol combining IR-SWIET with MP2RAGE, in which leukocortical lesions are well seen, improves cortical lesion visualization over existing approaches. Therefore, IR-SWIET may enable improved MS diagnostic specificity and a better understanding of the clinical implications of cortical demyelination.
OBJECTIVES: Cortical demyelination is common in multiple sclerosis (MS) and can be extensive. Cortical lesions contribute to disability independently from white matter lesions and may form via a distinct mechanism. However, current magnetic resonance imaging methods at 3 T are insensitive to cortical, and especially subpial cortical, lesions. Subpial lesions are well seen on T2*-weighted imaging at 7 T, but T2*-weighted methods on 3 T scanners are limited by poor lesion-to-cortex and cerebrospinal fluid-to-lesion contrast. We aimed to develop and evaluate a cerebrospinal fluid-suppressed, T2*-weighted sequence optimized for subpial cortical lesion visualization. MATERIALS AND METHODS: We developed a new magnetic resonance imaging sequence, inversion recovery susceptibility weighted imaging with enhanced T2 weighting (IR-SWIET; 0.8 mm × 0.8 mm in plane, 0.64 mm slice thickness with whole brain coverage, acquisition time ~5 minutes). We compared cortical lesion visualization independently on IR-SWIET (median signal from 4 acquisitions), magnetization-prepared 2 rapid acquisition gradient echoes (MP2RAGE), double inversion recovery (DIR), T2*-weighted segmented echo-planar imaging, and phase-sensitive inversion recovery images for 10 adults with MS. We also identified cortical lesions with a multicontrast reading of IR-SWIET (median of 2 acquisitions), MP2RAGE, and fluid-attenuated inversion recovery (FLAIR) images for each case. Lesions identified on 3 T images were verified on "gold standard" 7 T T2* and MP2RAGE images. RESULTS: Cortical, and particularly subpial, lesions appeared much more conspicuous on IR-SWIET compared with other 3 T methods. A total of 101 true-positive subpial lesions were identified on IR-SWIET (average per-participant sensitivity vs 7 T, 29% ± 8%) versus 36 on MP2RAGE (5% ± 2%; comparison to IR-SWIET sensitivity, P = 0.07), 17 on FLAIR (2% ± 1%; P < 0.05), 28 on DIR (6% ± 2%; P < 0.05), 42 on T2*-weighted segmented echo-planar imaging (11% ± 5%; P < 0.05), and 13 on phase-sensitive inversion recovery (4% ± 2%; P < 0.05). When a combination of IR-SWIET, MP2RAGE, and FLAIR images was used, a total of 147 subpial lesions (30% ± 5%) were identified versus 83 (16% ± 3%, P < 0.01) on a combination of DIR, MP2RAGE, and FLAIR. More cases had at least 1 subpial lesion on IR-SWIET, and IR-SWIET improved cortical lesion subtyping accuracy and correlation with 7 T subpial lesion number. CONCLUSIONS: Subpial lesions are better visualized on IR-SWIET compared with other 3 T methods. A 3 T protocol combining IR-SWIET with MP2RAGE, in which leukocortical lesions are well seen, improves cortical lesion visualization over existing approaches. Therefore, IR-SWIET may enable improved MS diagnostic specificity and a better understanding of the clinical implications of cortical demyelination.
Authors: Varun Sethi; Tarek Yousry; Nils Muhlert; Daniel J Tozer; Daniel Altmann; Maria Ron; Claudia Wheeler-Kingshott; David H Miller; Declan T Chard Journal: J Neurol Neurosurg Psychiatry Date: 2015-08-13 Impact factor: 10.154
Authors: E Mark Haacke; Norman Y C Cheng; Michael J House; Qiang Liu; Jaladhar Neelavalli; Robert J Ogg; Asadullah Khan; Muhammad Ayaz; Wolff Kirsch; Andre Obenaus Journal: Magn Reson Imaging Date: 2005-01 Impact factor: 2.546
Authors: Masaki Fukunaga; Tie-Qiang Li; Peter van Gelderen; Jacco A de Zwart; Karin Shmueli; Bing Yao; Jongho Lee; Dragan Maric; Maria A Aronova; Guofeng Zhang; Richard D Leapman; John F Schenck; Hellmut Merkle; Jeff H Duyn Journal: Proc Natl Acad Sci U S A Date: 2010-02-03 Impact factor: 11.205
Authors: Varun Sethi; Tarek A Yousry; Nils Muhlert; Maria Ron; Xavier Golay; Claudia Wheeler-Kingshott; David H Miller; Declan T Chard Journal: J Neurol Neurosurg Psychiatry Date: 2012-07-17 Impact factor: 10.154
Authors: A Scott Nielsen; R Philip Kinkel; Emanuele Tinelli; Thomas Benner; Julien Cohen-Adad; Caterina Mainero Journal: J Magn Reson Imaging Date: 2011-11-01 Impact factor: 4.813
Authors: Martina Absinta; Luisa Vuolo; Anuradha Rao; Govind Nair; Pascal Sati; Irene C M Cortese; Joan Ohayon; Kaylan Fenton; María I Reyes-Mantilla; Dragan Maric; Peter A Calabresi; John A Butman; Carlos A Pardo; Daniel S Reich Journal: Neurology Date: 2015-04-17 Impact factor: 9.910
Authors: Daniel M Harrison; Snehashis Roy; Jiwon Oh; Izlem Izbudak; Dzung Pham; Susan Courtney; Brian Caffo; Craig K Jones; Peter van Zijl; Peter A Calabresi Journal: JAMA Neurol Date: 2015-09 Impact factor: 18.302
Authors: José P Marques; Tobias Kober; Gunnar Krueger; Wietske van der Zwaag; Pierre-François Van de Moortele; Rolf Gruetter Journal: Neuroimage Date: 2009-10-09 Impact factor: 6.556
Authors: Jiaen Liu; Erin S Beck; Stefano Filippini; Peter van Gelderen; Jacco A de Zwart; Gina Norato; Pascal Sati; Omar Al-Louzi; Hadar Kolb; Maxime Donadieu; Mark Morrison; Jeff H Duyn; Daniel S Reich Journal: Invest Radiol Date: 2021-07-01 Impact factor: 10.065
Authors: David Pitt; Chih Hung Lo; Susan A Gauthier; Richard A Hickman; Erin Longbrake; Laura M Airas; Yang Mao-Draayer; Claire Riley; Philip Lawrence De Jager; Sarah Wesley; Aaron Boster; Ilir Topalli; Francesca Bagnato; Mohammad Mansoor; Olaf Stuve; Ilya Kister; Daniel Pelletier; Panos Stathopoulos; Ranjan Dutta; Matthew R Lincoln Journal: Neurol Neuroimmunol Neuroinflamm Date: 2022-08-30
Authors: Francesco La Rosa; Erin S Beck; Josefina Maranzano; Ramona-Alexandra Todea; Peter van Gelderen; Jacco A de Zwart; Nicholas J Luciano; Jeff H Duyn; Jean-Philippe Thiran; Cristina Granziera; Daniel S Reich; Pascal Sati; Meritxell Bach Cuadra Journal: NMR Biomed Date: 2022-03-31 Impact factor: 4.478